PPAR-γ agonists preserved the fluidity of the myocardial cell membrane and reduced cardiac injury in hypercholesterolemia rats although pioglitazone could also decrease myocardial infarct size through PPAR-γ-independent mechanisms [17, 18]. This evidence concerns the gene PPARG and Hypercholesterolemia.